Parkinson hastalığında anksiyete ve motor semptomların yönetimi.
Management of anxiety and motor symptoms in Parkinson's disease.
DOI: 10.1586/14737175.2014.936388PMID: 25056382
Management of anxiety and motor symptoms in Parkinson's disease.
DOI: 10.1586/14737175.2014.936388PMID: 25056382
Giant Virchow-Robin spaces as an incidental finding in a patient with parkinsonism.
DOI: 014178/aim.0012PMID: 25065284
Postural instability in Parkinson's disease - 120 years after Charcot's death.
DOI: 10.1590/0004-282x20140085PMID: 25098480
Lesson of the month 2: a case of coma in a Parkinson's patient: a combination of fatigue, dehydration and high protein diet over the New Year period?
DOI: 10.7861/clinmedicine.14-4-449PMID: 25099854
Moderate evidence exists for occupational therapy-related interventions for people with Parkinson's disease in physical activity training, environmental cues and individualised programmes promoting personal control and quality of life.
DOI: 10.1111/1440-1630.12153PMID: 25154449
Abnormal high-frequency burst firing of cerebellar neurons in rapid-onset dystonia-parkinsonism.
DOI: 10.1523/jneurosci.1409-14.2014PMID: 25164667
Inhibition of adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an animal model of Parkinson's disease.
DOI: 10.1523/jneurosci.0864-14.2014PMID: 25164669
The effects of brain stimulation of subthalamic nucleus surgery on gait and balance performance in Parkinson disease. A pilot study.
DOI: 10.5114/aoms.2012.31371PMID: 25276158
[Cognitive dysfuctions associated with essential tremor and Parkinson's disease].
PMID: 25400045
Applications of visual evoked potentials and Fourier-domain optical coherence tomography in Parkinson's disease: a controlled study.
DOI: 10.5935/0004-2749.20140061PMID: 25410176
[Neurological common diseases in the super-elder society. Topics: IV. Parkinson's disease; 1. The noticeable earrly symptoms of Parkinson's disease].
DOI: 10.2169/naika.103.1854PMID: 25654880
[Neurological common diseases in the super-elder society. Topics: IV. Parkinson's disease; 2. Current and new drugs for initial treatment of Parkinson's disease].
DOI: 10.2169/naika.103.1861PMID: 25654881
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.